- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Non-Genetic Risk Factors of Alzheimer’s Disease: An Updated Umbrella Review ; volume:11 ; number:4 ; day:29 ; month:5 ; year:2024 ; pages:917-927 ; date:8.2024
The journal of prevention of Alzheimer's disease ; 11, Heft 4 (29.5.2024), 917-927, 8.2024
- Creator
-
He, S.-Y
Su, W.-M
Wen, X.-J
Lu, S.-J
Cao, B.
Yan, Bo
Chen, Yong-Ping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2024.100
- URN
-
urn:nbn:de:101:1-2410100704287.587591697177
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- He, S.-Y
- Su, W.-M
- Wen, X.-J
- Lu, S.-J
- Cao, B.
- Yan, Bo
- Chen, Yong-Ping
- SpringerLink (Online service)
Other Objects (12)
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
Education and Genetic Risk Modulate Hippocampal Structure in Alzheimer’s Disease
Multidimensional evaluation in clinical diagnosis of Alzheimer’s disease: genetic risk in Alzheimer’s disease and neurodegenerative dementias
Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease
Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis
Network dynamics-based subtyping of Alzheimer’s disease with microglial genetic risk factors
APOE4 rat model of Alzheimer’s disease: sex differences, genetic risk and diet
Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease
Genetic-based patient stratification in Alzheimer’s disease
Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
Education and Genetic Risk Modulate Hippocampal Structure in Alzheimer’s Disease
Multidimensional evaluation in clinical diagnosis of Alzheimer’s disease: genetic risk in Alzheimer’s disease and neurodegenerative dementias
Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease
Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis
Network dynamics-based subtyping of Alzheimer’s disease with microglial genetic risk factors
APOE4 rat model of Alzheimer’s disease: sex differences, genetic risk and diet
Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease
Genetic-based patient stratification in Alzheimer’s disease
Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
Education and Genetic Risk Modulate Hippocampal Structure in Alzheimer’s Disease
Multidimensional evaluation in clinical diagnosis of Alzheimer’s disease: genetic risk in Alzheimer’s disease and neurodegenerative dementias
Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease
Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis
Network dynamics-based subtyping of Alzheimer’s disease with microglial genetic risk factors
APOE4 rat model of Alzheimer’s disease: sex differences, genetic risk and diet
Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease
Genetic-based patient stratification in Alzheimer’s disease
Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction